Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Spectrum Pharma: Q4 2009 Loss Anticipated - - - - Guidance Is Key

|Includes: Spectrum Pharmaceuticals, Inc. (SPPI)
Spectrum Pharmaceuticals (NASDAQ:SPPI)

This company will either get its stuff together or it won't.  Manage the risks, CYA.

Perspective
Cell Therapeutics (NASDAQ:CTIC) has nothing remotely close to being approved. Yet, CTIC maintains a market cap of $290 M.  SPPI maintains a market cap of $239 million after yesterday's ridiculous sell-off.

Before overreacting to every headline, investors should try to keep things in perspective.

My bet, SPPI will get there eventually.


Disclosure:
Long SPPI.